# Immunoadsorption for Treatment of Alzheimer's Disease

> **NCT03132272** · NA · TERMINATED · sponsor: **University Medicine Greifswald** · enrollment: 11 (actual)

## Conditions studied

- Alzheimer Dementia

## Interventions

- **DEVICE:** Immunoadsorption with Globaffin

## Key facts

- **NCT ID:** NCT03132272
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-15
- **Primary completion:** 2020-10-12
- **Final completion:** 2020-10-12
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** slow recruiting, difficulties in finding eligible patients
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132272, "Immunoadsorption for Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03132272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*